
3.08BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US45166A1025
CUSIP
45166A102
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
12.44
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.92
Wall Street Target Price
51.92
EPS Estimate Current Year
-4.59
EPS Estimate Next Year
-4.11
EPS Estimate Current Quarter
-1.0502
EPS Estimate Next Quarter
-1.0398
Most Recent Quarter
-
Revenue TTM
234,127,008
Gross Profit TTM
-139,880,000
EBITDA
-214,195,008
Profit Margin
-74.75%
Return On Assets TTM
-11.54%
Return On Equity TTM
-16.22%
Revenue Per Share TTM
2.617
Qtly Revenue Growth YOY
55.40%
Diluted Eps TTM
-1.92
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
4
Price Sales TTM
13.0396
Price Book MRQ
2.569
Enterprise Value Revenue
9
Enterprise Value EBITDA
-7
903.08
3.20%227.40
2.97%965.00
0.55%314.92
0.35%900.30
0.00%139.16
0.00%528.21
-4.77%355.10
-2.26%34.64
-2.01%153.70
-1.47%